FDA Approves Cyltezo, the First Interchangeable Biosimilar to Humira
Second Interchangeable Biosimilar Product Approved by Agency SILVER SPRING, Md., Oct. 18, 2021 -- (Healthcare Sales & Marketing Network) -- The U.S. Food and Drug Administration approved the first interchangeable biosimilar product to treat certain inf... Biopharmaceuticals, Generics, FDA Boehringer Ingelheim, Cyltezo, Humira, adalimumab, biosimilar (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2021 Category: Pharmaceuticals Source Type: news

NeuExcell Therapeutics names Lori Gavrin as Chief Business and Strategy Officer
STATE COLLEGE, Penn., Oct. 18, 2021 -- (Healthcare Sales & Marketing Network) -- NeuExcell Therapeutics Inc. (www.neuexcell.com) today announced the appointment of Lori Gavrin, Ph.D. to the new position of Chief Business and Strategy Officer, effective im... Biopharmaceuticals, Personnel NeuExcell Therapeutics, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2021 Category: Pharmaceuticals Source Type: news

Oyster Point Pharma Announces FDA Approval of TYRVAYA(TM) (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
TYRVAYA is the first and only nasal spray approved for the treatment of the signs and symptoms of dry eye disease TYRVAYA is designed to activate the trigeminal parasympathetic pathway resulting in increased production of basal tear film as a treatment ... Biopharmaceuticals, Ophthalmology, FDA Oyster Point Pharma, TYRVAYA, varenicline, dry eye disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2021 Category: Pharmaceuticals Source Type: news

SpinaFX Medical announces John Soloninka as Chief Operating Officer
TORONTO, Oct. 15, 2021 -- (Healthcare Sales & Marketing Network) - Minimally invasive image-guided therapy start-up, SpinaFX Medical Inc. (SpinaFX), is pleased to announce the appointment of John Soloninka as Chief Operating Officer. John is a healthte... Devices, Neurosurgery, Orthopaedic, Personnel SpinaFX Medical, Triojection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 15, 2021 Category: Pharmaceuticals Source Type: news

Aspaveli(R) (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
STOCKHOLM, Oct. 15, 2021 -- (Healthcare Sales & Marketing Network) -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) and Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announce today that the Committee for Medicinal Products for Human Use (CHMP) of t... Biopharmaceuticals, Regulatory Swedish Orphan Biovitrum, Sobi , Apellis Pharmaceuticals, Aspaveli (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 15, 2021 Category: Pharmaceuticals Source Type: news

NuVasive Launches Latest Porous PEEK Implant for Posterior Spine Surgery
SAN DIEGO, Oct. 14, 2021 -- (Healthcare Sales & Marketing Network) -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today annou... Devices, Neurosurgery, Orthopaedic, Product Launch NuVasive, Cohere TLIF-O, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 14, 2021 Category: Pharmaceuticals Source Type: news

Immunic, Inc. Appoints Patrick Walsh as Chief Business Officer
NEW YORK, Oct. 14, 2021 -- (Healthcare Sales & Marketing Network) -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimm... Biopharmaceuticals, Personnel Immunic , immune modulator (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 14, 2021 Category: Pharmaceuticals Source Type: news

Varian Receives FDA "Breakthrough Device Designation" For Embozene(R) Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis
PALO ALTO, Calif., Oct. 13, 2021 -- (Healthcare Sales & Marketing Network) -- Varian, a Siemens Healthineers company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough Device Designation for its Embozene... Devices, Interventional, FDA Varian, Embozene, Microspheres, Genicular Artery Embolization, Osteoarthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 13, 2021 Category: Pharmaceuticals Source Type: news

Poseida Therapeutics Announces Leadership Appointments
SAN DIEGO, Oct. 13, 2021 -- (Healthcare Sales & Marketing Network) -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutic... Biopharmaceuticals, Personnel Poseida Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 13, 2021 Category: Pharmaceuticals Source Type: news

Laborie Medical Technologies Acquires Pelvalon
PORTSMOUTH, N.H., Oct. 13, 2021 -- (Healthcare Sales & Marketing Network) -- Laborie Medical Technologies Corp. (Laborie) a specialist medical technology company, announced today that it has acquired Pelvalon, Inc., a privately held medical device company... Devices, Mergers & Acquisitions Laborie Medical Technologies, Pelvalon, Eclipse System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 13, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Verzenio(R) (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer
Adding Verzenio to endocrine therapy demonstrated a significant and clinically meaningful reduction in the risk of recurrence in patients with HR+ HER2-, node-positive, high risk early breast cancer and a Ki-67 score of ≥20% Verzenio is the first ... Biopharmaceuticals, Oncology, FDA Eli Lilly, Verzenio, abemaciclib, breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 13, 2021 Category: Pharmaceuticals Source Type: news

Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson and Johnson To Retire, Effective December 31, 2021
NEW BRUNSWICK, N.J., Oct. 12, 2021 -- (Healthcare Sales & Marketing Network) -- Johnson & Johnson (NYSE: JNJ) today announced that Paul Stoffels M.D., currently Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson, wi... Biopharmaceuticals, Personnel Johnson & Johnson (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 12, 2021 Category: Pharmaceuticals Source Type: news

Andreas Tsukada Joins Caris Life Sciences as President of Japanese Operations and Head of International
IRVING, Texas, Oct. 12, 2021 -- (Healthcare Sales & Marketing Network) -- Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, announced today that Andreas S. Tsukada has joined the Comp... Diagnostics, Personnel Caris Life Sciences, precision medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 12, 2021 Category: Pharmaceuticals Source Type: news

Sirtex Medical and China Grand Pharmaceutical announce successful first administration of SIR-Spheres(R) Y-90 resin microspheres in China
WOBURN, Mass., Oct. 11, 2021 -- (Healthcare Sales & Marketing Network) -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today that the first procedure of selective internal radiation therapy (SIR... Devices, Oncology Sirtex Medical, SIR-Spheres, Y-90 resin microspheres, hepatocellular carcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 11, 2021 Category: Pharmaceuticals Source Type: news

Medtronic Hugo(TM) Robotic-Assisted Surgery System Receives European CE Mark Approval
Multiple Hospitals Across Europe Set to be the First to Install Hugo™ RAS System and Expand the Benefits of Robotic-Assisted Surgery to Their Patients DUBLIN, Oct. 11, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT), the glob... Devices, Surgery, Regulatory Medtronic, Hugo RAS system, robotic-assisted surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 11, 2021 Category: Pharmaceuticals Source Type: news

18-Month Below-the-Knee Data with MedAlliance's SELUTION SLR(TM) Presented as Late Breaking Trial at VIVA
The objective of this clinical investigation has been to eval... Devices, Interventional MedAlliance, SELUTION SLR, Sirolimus, Drug Eluting Balloon (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 8, 2021 Category: Pharmaceuticals Source Type: news

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM
JERUSALEM, Oct. 8, 2021 -- (Healthcare Sales & Marketing Network) -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to announce that it has received Breakthrough Device Designation for Alpha DaRT ... Devices, Oncology Alpha Tau Medical, Alpha DaRT, glioblastoma multiforme (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 8, 2021 Category: Pharmaceuticals Source Type: news

Venclose MAVEN Earns FDA Clearance to Treat Incompetent Perforator Veins
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years SAN JOSE, Calif., Oct. 7, 2021 -- (Healthcare Sales & Marketing Network) -- Venclose Inc., a privately-held Silicon Valley medical d... Devices, Interventional, FDA Venclose , Maven catheter, radiofrequency catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 7, 2021 Category: Pharmaceuticals Source Type: news

AffyImmune Therapeutics Announces $30M Series A+ Financing from ORI Capital
NATICK, Mass., Oct. 7, 2021 -- (Healthcare Sales & Marketing Network) -- AffyImmune Therapeutics, Inc., a clinical stage biotechnology company developing and deploying its Tune & Track platform for the use of CAR T cells to treat solid tumors, announced t... Biopharmaceuticals, Venture Capital AffyImmune Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 7, 2021 Category: Pharmaceuticals Source Type: news

Tris Pharma(R) Hires Seasoned Business Development Executive
Anthony Amato joins as Executive Vice President Business Development - Generics Division MONMOUTH JUNCTION, N.J., Oct. 7, 2021 -- (Healthcare Sales & Marketing Network) -- Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a ... Biopharmaceuticals, Generics, Personnel Tris Pharma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 7, 2021 Category: Pharmaceuticals Source Type: news

Amgen and Neumora Therapeutics Announce Strategic RandD Collaboration to Accelerate Novel Precision Therapies for Brain Diseases
Collaboration Leveraging Neumora's Precision Neuroscience Platform with Amgen's deCODE Human Genetics Capabilities to Advance Innovative Medicines for Brain Disease THOUSAND OAKS, Calif. and WATERTOWN, Mass., Oct. 7, 2021 -- (Healthcare Sales & Marketin... Biopharmaceuticals, Neurology Amgen, Neumora Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 7, 2021 Category: Pharmaceuticals Source Type: news

SAGA Diagnostics appoints Peter Collins as Chief Executive Officer
LUND, Sweden, Oct. 7, 2021 -- (Healthcare Sales & Marketing Network) -- SAGA Diagnostics AB ("SAGA"), a leading cancer liquid biopsy and genomic testing company, has announced the appointment of Peter Collins as Chief Executive Officer. Mr. ... Diagnostics, Personnel SAGA Diagnostics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 7, 2021 Category: Pharmaceuticals Source Type: news

U.S. FDA Accepts COUR Pharmaceuticals Investigational New Drug Application (IND) for a Proof-of-Concept Study for the Treatment of Primary Biliary Cholangitis (PBC)
Clinical study aims to investigate the safety and efficacy of CNP-104 in PBC patients with alkaline phosphatase (ALP)> 1.5x upper limit of normal (ULN) CHICAGO, Oct. 4, 2021 -- (Healthcare Sales & Marketing Network) -- COUR Pharmaceuticals, a biote... Biopharmaceuticals, FDA COUR Pharmaceuticals, Primary Biliary Cholangitis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 6, 2021 Category: Pharmaceuticals Source Type: news

Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.
Acquisition to add new left heart access platforms to electrophysiology and structural heart portfolios MARLBOROUGH, Mass., Oct. 6, 2021 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced that it has ... Devices, Cardiology, Mergers & Acquisitions Boston Scientific, Baylis Medical Company, VersaCross (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 6, 2021 Category: Pharmaceuticals Source Type: news

BD Announces 510(k) Clearance of Expanded Indications for the Rotarex(TM) Atherectomy System
Rotarex™ Rotational Excisional Atherectomy System is the first and only atherectomy and thrombectomy device indicated to treat in-stent restenosis in the United States FRANKLIN LAKES, N.J., Oct. 6, 2021 -- (Healthcare Sales & Marketing Network) -- BD (... Devices, Interventional, FDA BD , Rotarex Atherectomy System, atherectomy, thrombectomy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 6, 2021 Category: Pharmaceuticals Source Type: news

GC Aesthetics(R) Achieves Compelling Surgical And Patient Care Results With FixNip NRI(TM), The Revolutionary Nipple Reconstruction Device
DUBLIN, Oct. 5, 2021 -- (Healthcare Sales & Marketing Network) -- GC Aesthetics®, Inc. (GCA), a privately-held medical technology company providing aesthetic solutions for global healthcare markets, announces successful surgical and patient care resul... Devices, Surgery GC Aesthetics, FixNip NRI, nipple reconstruction (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 5, 2021 Category: Pharmaceuticals Source Type: news

Amber Implants VCFix(R) spinal system receives US FDA Breakthrough designation
Set to vastly improve treatment of vertebral fractures HAGUE, Netherlands, Oct. 5, 2021 -- (Healthcare Sales & Marketing Network) -- Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries... Devices, Orthopaedic, Neurosurgery, FDA Amber Implants, VCFix spinal system, vertebral fracture (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 5, 2021 Category: Pharmaceuticals Source Type: news

Novavax Announces Leadership Appointment and Updates
Denny Kim, M.D. appointed Senior Vice President, Chief Safety Officer Raburn Mallory, M.D. promoted to Senior Vice President, Head of Clinical Development Marco Cacciuttolo, Ph.D. promoted to Senior Vice President, Process and Analytical Development ... Biopharmaceuticals, Personnel Novavax, vaccine, NanoFlu, influenza, COVID-19 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 4, 2021 Category: Pharmaceuticals Source Type: news

C-RAD and Accuray Sign Agreement to Enhance Radixact(R) System Breast Cancer Treatment Capabilities
UPPSALA, Sweden, and SUNNYVALE, Calif., Oct. 4, 2021 -- (Healthcare Sales & Marketing Network) -- C-RAD AB (NASDAQ Stockholm: CRAD B) and Accuray Incorporated (NASDAQ: ARAY) announced today they have signed an agreement designed to enhance the Accuray Rad... Devices, Oncology Accuray, C-RAD AB, Radixact System, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 4, 2021 Category: Pharmaceuticals Source Type: news

CoreBone Raises $3.7 Million Investment to Commercialize its Bioactive Bone Graft Material for Dental and Orthopedic Treatments and Expand Activity in China
TEL AVIV, Israel, Oct. 4, 2021 -- (Healthcare Sales & Marketing Network) -- CoreBone, a company that produces bioactive, coral-based bone graft material, announced that it has completed an investment round of $3.7 million. The Guangzhou Sino-Israel Biotec... Devices, Orthopaedic, Dental, Venture Capital CoreBone, bioactive bone graft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 4, 2021 Category: Pharmaceuticals Source Type: news

SpinaFX Medical announces Jeff Cambra as CEO
TORONTO, Oct. 1, 2021 -- (Healthcare Sales & Marketing Network) - Minimally invasive image-guided therapy start-up, SpinaFX Medical Inc. (SpinaFX), is pleased to announce the appointment of Jeff Cambra as Chief Executive Officer. Mr. Cambra is a vetera... Devices, Orthopaedic, Neurosurgery, Personnel SpinaFX Medical, Triojection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 1, 2021 Category: Pharmaceuticals Source Type: news

Breckenridge Announces Launch of its 10mg strength for Everolimus Tablets (generic for Afinitor(R))
BERLIN, Conn., Oct. 1, 2021 -- (Healthcare Sales & Marketing Network) -- Breckenridge Pharmaceutical, Inc. announces today that it has launched the 10mg strength of Everolimus Tablets (generic for Afinitor®). The U.S. Food and Drug Administration pre... Biopharmaceuticals, Generics, Product Launch Breckenridge Pharmaceutical, Natco Pharma, everolimus, Afinitor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 1, 2021 Category: Pharmaceuticals Source Type: news

Medtronic Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies
Industry Leading Portfolio of Integrated Solutions Sets a New Standard for Minimally Invasive Spine Procedures, Beginning with MIS+ TLIF DUBLIN, Sept. 30, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE: MDT), the global leader in... Devices, Orthopaedic, Neurosurgery, Product Launch Medtronic, Catalyft, Space-D, Accelerate Graft Delivery System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 30, 2021 Category: Pharmaceuticals Source Type: news

Electromedical Technologies Receives Key Medical Device Certification
SCOTTSDALE, Ariz., Sept. 30, 2021 -- (Healthcare Sales & Marketing Network) -- Electromedical Technologies, Inc. (OTCQB: EMED) (the "Company"), a pioneer in the development and production of bioelectronic devices designed to relieve chronic, int... Devices, Regulatory Electromedical Technologies, WellnessPro POD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 30, 2021 Category: Pharmaceuticals Source Type: news

OLUMIANT(R) Significantly Improved Hair Regrowth to At Least 80% Scalp Coverage as Early as 24 Weeks Across First Completed Phase 3 Studies for Alopecia Areata
INDIANAPOLIS, Sept. 30, 2021 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today detailed results from two pivotal Phase 3 trials (BRAVE-AA1 and BRAVE-AA2), which found once-daily OLUMIA... Biopharmaceuticals Eli Lilly, OLUMIANT, baricitinib, alopecia areata (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 30, 2021 Category: Pharmaceuticals Source Type: news

French Hospital Network Unicancer Acquires Multiple Accuray Radixact(R) Systems with the ClearRT(TM) Helical Fan-Beam kVCT Imaging and Synchrony(R) Technologies
More than 30 Accuray TomoTherapy® and CyberKnife® Platform Systems Are Currently in Use at Unicancer, the Largest Network of Comprehensive Cancer Centers in Europe SUNNYVALE, Calif., Sept. 29, 2021 -- (Healthcare Sales & Marketing Network) -- A... Devices, Oncology Accuray, Radixact System, ClearRT, radiosurgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 29, 2021 Category: Pharmaceuticals Source Type: news

TransMedics Receives FDA Approval for its OCS Liver System for Preservation and Assessment of Donor Livers for Transplantation
ANDOVER, Mass., Sept. 29, 2021 -- (Healthcare Sales & Marketing Network) -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, hear... Devices, FDA TransMedics Group, OCS Liver System, portable extracorporeal (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 29, 2021 Category: Pharmaceuticals Source Type: news

Neurolens Names Mark Kremer Chief Revenue Officer
CEO Pierre Bertrand continues to grow the Leadership Team COPPELL, Texas, Sept. 29, 2021 -- (Healthcare Sales & Marketing Network) -- Following his announcement as CEO, Pierre Bertrand has simplified the leadership structure of Neurolens to ensure unif... Devices, Ophthalmology, Personnel Neurolens (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 29, 2021 Category: Pharmaceuticals Source Type: news

Cartesian Therapeutics Strengthens Leadership Team With Hire of Miloš Miljkoviand#263;, M.D., as Chief Medical Officer
Former CMO Metin Kurtoglu, M.D., Ph.D., appointed as the Company's first Chief Operating Officer Cartesian expands cGMP manufacturing facility to support growing clinical pipeline GAITHERSBURG, Md., Sept. 28, 2021 -- (Healthcare Sales & Marketing Net... Biopharmaceuticals, Oncology, Personnel Cartesian Therapeutics, RNA cell therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 28, 2021 Category: Pharmaceuticals Source Type: news

ONO PHARMA USA Appoints David Trexler as Chief Commercial Officer to Strengthen U.S. Leadership
Mr. Trexler to lead the commercial infrastructure for tirabrutinib and other compounds in oncology pipeline CAMBRIDGE, Mass., Sept. 28, 2021 -- (Healthcare Sales & Marketing Network) -- ONO PHARMA USA, INC. (President and CEO, Kunihiko Ito, "OPUS&... Biopharmaceuticals, Personnel ONO PHARMA USA, tirabrutinib (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 28, 2021 Category: Pharmaceuticals Source Type: news

Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
Portfolio Features First Catheter Specifically Designed to Allow Neurointerventionalists Radial Artery Access, Delivers Advantages to Patients Treated for Stroke, Brain Aneurysms, Other Neurovascular Conditions Now Available in the United Kingdom, Italy... Devices, Interventional, Regulatory Medtronic, radial artery access, Rist 079 Radial (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 28, 2021 Category: Pharmaceuticals Source Type: news

Open Stent Solution closes €2.5M Seed financing round for its breakthrough open-stent TMVR device
AMIENS, France, Sept. 28, 2021 -- (Healthcare Sales & Marketing Network) -- Open Stent Solution (OSS), a medtech start-up company developing the first open-stent heart valves, today announced the closing of a €2.5 million Seed financing round. The funding... Devices, Interventional, Cardiology, Venture Capital Open Stent Solution, open-stent heart valves, OSS valve, mitral valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 28, 2021 Category: Pharmaceuticals Source Type: news

Ortho Clinical Diagnostics Announces Launch of New ISXM Capabilities
New Menu Capability Now Available on VISION and VISION MAX Analyzers Increases Confidence in Blood Transfusion-Related Test Results RARITAN, N.J., Sept. 27, 2021 -- (Healthcare Sales & Marketing Network) -- Ortho Clinical Diagnostics (NASDAQ: OCDX), on... Diagnostics, Product Launch Ortho Clinical Diagnostics, Immediate Spin Crossmatch, blood transfusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 27, 2021 Category: Pharmaceuticals Source Type: news

Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders
Funding to rapidly advance Delix's novel non-hallucinatory, take-home, neuroplasticity-promoting candidates into clinical trials to better treat mental illness and other brain disorders at scale BOSTON, Sept. 27, 2021 -- (Healthcare Sales & Marketing Ne... Biopharmaceuticals, Neurology, Venture Capital Delix Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 27, 2021 Category: Pharmaceuticals Source Type: news

Synlogic Appoints Molly Harper as Chief Business Officer
CAMBRIDGE, Mass., Sept. 27, 2021 -- (Healthcare Sales & Marketing Network) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced the appointment of Molly Harper a... Biopharmaceuticals, Personnel Synlogic , synthetic biology, synthetic biotics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 27, 2021 Category: Pharmaceuticals Source Type: news

Japan's MHLW Approves PADCEV(R) (enfortumab vedotin) for Advanced Urothelial Cancer
Enfortumab vedotin is the first and only antibody-drug conjugate (ADC) approved in Japan for patients with advanced urothelial cancer TOKYO and BOTHELL, Wash., Sept. 27, 2021 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE:4503,... Biopharmaceuticals, Urology, Oncology, Regulatory Astellas Pharma, enfortumab vedotin, urothelial cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 27, 2021 Category: Pharmaceuticals Source Type: news

First Procedure in Asia-Pacific Performed with Medtronic Hugo(TM) Robotic-Assisted Surgery System
The Robotic Prostatectomy Took Place at Apollo Hospitals, Greams Road, Chennai, India DUBLIN and CHENNAI, India, Sept. 27, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE:MDT) and Apollo Hospitals Group today announced the first c... Devices, Surgery Medtronic, Hugo RAS system, robotic-assisted surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 27, 2021 Category: Pharmaceuticals Source Type: news

Intelivation Technologies Launches Advantage-C(TM) PEEK Cervical Interbody Fusion Device
SAINT SIMONS ISLAND, Ga., Sept. 24, 2021 -- (Healthcare Sales & Marketing Network) -- Intelivation Technologies, a medical device company with a growing product portfolio announced today that they are officially launching the Advantage-C™ PEEK Interbody F... Devices, Orthopaedic, Neurosurgery, Product Launch Intelivation Technologies, Advantage-C, Cervical Interbody Fusion (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 24, 2021 Category: Pharmaceuticals Source Type: news

DiNAQOR Appoints Medical Device Leader Mark Dehdashtian to Oversee New U.S.-Based Division, Device Development and Production
ZURICH-SCHLIEREN, Switzerland and LAGUNA HILLS, Calif., Sept. 23, 2021 -- (Healthcare Sales & Marketing Network) -- DiNAQOR, a genetic medicine platform company focused on addressing severe inherited cardiac diseases, today announced it has expanded its l... Devices, Personnel DiNAQOR, genetic medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 23, 2021 Category: Pharmaceuticals Source Type: news

MolecuLight i:X(R) Receives FDA 510(k) Clearance for the Device's Ability to Detect Wounds Likely to Contain Pseudomonas aeruginosa (PA)
New FDA Clearance Illustrates the Utility of the i:X to Reliably Predict Pseudomonas aeruginosa, a Bacterial Pathogen that Precludes Wound Healing and Often Evades Conventional Treatment Methods TORONTO, Sept. 23, 2021 -- (Healthcare Sales & Marketing N... Devices, Wound Care, FDA MolecuLight, MolecuLight i:X, fluorescence imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 23, 2021 Category: Pharmaceuticals Source Type: news